Pharmaceutical Commerce Magazine

09/12/2024

The parties’ want to provide customers with a “one-stop-shop,” with the hopes that their services will be easier to navigate.

09/12/2024

Business strategies and top news in the biotech / biopharma industry, including market access, supply chain distribution and more.

09/11/2024

A pooled analysis of the SWIFT-1 and SWIFT-2 trials found 54% reduction in exacerbation rates over 52 weeks in patients with severe asthma with type 2 inflammation treated with depemokimab.

09/11/2024

The latest news for pharma industry insiders.

09/10/2024

The latest news for pharma industry insiders.

09/09/2024

The latest news for pharma industry insiders.

09/05/2024

📍 Coverage from
Ilisa Bernstein, President of Bernstein Rx Solutions, LLC, discusses the best practices that compliance teams should consider as the end of the stabilization period approaches this November.

In the second part of her interview with Pharma Commerce Editor Nicholas Saraceno, Ilisa B.G. Bernstein, President of Bernstein Rx Solutions, LLC, discusses the best practices that compliance teams should consider as the end of the stabilization period approaches this November.

09/05/2024

Business strategies and top news in the biotech / biopharma industry, including market access, supply chain distribution and more.

09/04/2024

The latest news for pharma industry insiders.

09/03/2024

How can industry stakeholders ensure the quality and supply chain security of existing product?🖋️ Dan Bell, Senior Vice President, Innovation & Strategic Operations, Marken

How can industry stakeholders ensure the quality and supply chain security of existing product?

09/03/2024

The latest news for pharma industry insiders.

08/30/2024

📍 Coverage from
Panel offers suggestions on how compliance teams should be considering handling SOPs, stabilization, and much more.

Moderator: Ilisa Bernstein, president of Bernstein Rx Solutions, LLC

Panelists: Jennell Bilek, equity partner, Carlson Caspers; Chris Smith, senior counsel, Epstein Becker & Green, P.C.; and Theodore Sullivan, partner, Quarles & Brady LLP

Panel offers suggestions on how compliance teams should be considering handling SOPs, stabilization, and much more.